相关实验视频

Updated: May 8, 2026

Mapping Bacterial Functional Networks and Pathways in Escherichia Coli using Synthetic Genetic Arrays

Mapping Bacterial Functional Networks and Pathways in Escherichia Coli using Synthetic Genetic Arrays

Published on: November 12, 2012

基因改造核酶的染色目标和非目标效应通过蓝色和白色殖民地试验

Xumeng Chen¹, Li Xiao², Qian Wang²

¹National Engineering Research Center of Personalized Diagnostic and Therapeutic Technology, Hunan University of Chinese Medicine, Changsha, 410208, China.

Biotechnology letters

|November 7, 2025

概括

新的染色体分析提供了对CRISPR/Cas9基因编辑的敏感评估,这对于通过检测非目标效应来推进人类基因治疗至关重要. 这些测试改善了基因编辑技术的安全性评估.

科学领域:

分子生物学分子生物学
生物技术是生物技术.
基因治疗基因治疗

背景情况:

准确评估基因编辑核酶的脱效应对于安全的人类基因治疗至关重要.
克里斯普尔/Cas9技术对治疗应用具有前景,但需要严格的安全评估.

研究的目的:

开发敏感的染色体测试来评估基因编辑活动,特别是针对CRISPR/Cas9.
建立可靠的方法,用于对目标和非目标影响的定性和定量评估.

主要方法:

利用β-银酸酶α补充剂用于测试开发.
在E.coli殖民地使用颜色改变来评估CRISPR/Cas9基因编辑结果.
设计测试以检测目标部位和指导RNA (gRNAs) 中不匹配的基的非目标效应,包括不匹配的PAM部位.

主要成果:

成功建立了用于敏感评估CRISPR/Cas9基因编辑的染色体测试.
证明了能够以高灵敏度分析目标外效应,即使是单个基因不匹配.
启用识别基因编辑效应在非目标部位与一个基不匹配的PAM部位.

结论:

开发的染色体测试为评估CRISPR/Cas9基因编辑提供了灵敏,高效和多功能工具.
这些测试对于提高基因编辑技术在治疗开发中的安全性概况至关重要.
该方法方便对基因编辑特异性的全面分析,这对于临床翻译至关重要.

关键词:

蓝色和白色测试试验这就是CRISPR/Cas9的作用.非目标效应的影响在 PAM 站点上设置 PAM 站点.

更多相关视频

Rapid Verification of Terminators Using the pGR-Blue Plasmid and Golden Gate Assembly

Rapid Verification of Terminators Using the pGR-Blue Plasmid and Golden Gate Assembly

Published on: April 25, 2016

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells

Published on: August 25, 2017

相关概念视频

In-vitro Mutagenesis

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.

Position-effect Variegation

Position-effect Variegation

In 1928, a German botanist Emil Heitz observed the moss nuclei with a DNA binding dye. He observed that while some chromatin regions decondense and spread out in the interphase nucleus, others do not. He termed them euchromatin and heterochromatin, respectively. He proposed that the heterochromatin regions reflect a functionally inactive state of the genome. It was later confirmed that heterochromatin is transcriptionally repressed, and euchromatin is transcriptionally active chromatin.